Fingerprint
Dive into the research topics where Amy Spallone is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Albumin orchestrates a natural host defence mechanism against mucormycosis
Pikoulas, A., Morianos, I., Nidris, V., Hamdy, R., Intze, E., López-López, Á., Moran-Garrido, M., Muthu, V., Halabalaki, M., Papaioanou, V., Papadovasilaki, M., Kyrmizi, I., Gu, Y., Camunas-Alberca, S., Aerts, R., Mercier, T., Vanbiervliet, Y., Cho, S. Y., Spallone, A. & Jiang, Y. & 21 others, , Jan 15 2026, In: Nature. 649, 8097, p. 693-702 10 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Link opens in a new tab Scopus citations -
Author Correction: Albumin orchestrates a natural host defence mechanism against mucormycosis (Nature, (2026), 649, 8097, (693-702), 10.1038/s41586-025-09882-3)
Pikoulas, A., Morianos, I., Nidris, V., Hamdy, R., Intze, E., López-López, Á., Moran-Garrido, M., Muthu, V., Halabalaki, M., Papaioanou, V., Papadovasilaki, M., Kyrmizi, I., Gu, Y., Camunas-Alberca, S. M., Aerts, R., Mercier, T., Vanbiervliet, Y., Cho, S. Y., Spallone, A. & Jiang, Y. & 21 others, , Feb 19 2026, In: Nature. 650, 8102, p. E11-E11Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Outcomes and Risk Factors for Influenza and Respiratory Syncytial Virus Lower Respiratory Tract Infections and Mortality in Patients With Lymphoma or Multiple Myeloma: A 7-Year Retrospective Cohort Study
Shafat, T., De-La-Rosa-Martinez, D., Khawaja, F., Jiang, Y., Spallone, A., Batista, M. V., Ariza-Heredia, E., Vilar-Compte, D., Ahmed, S., Becnel, M. & Chemaly, R. F., Apr 1 2025, In: Open Forum Infectious Diseases. 12, 4, ofaf127.Research output: Contribution to journal › Article › peer-review
Open Access6 Link opens in a new tab Scopus citations -
Preventing Severe COVID-19 with Tixagevimab-Cilgavimab in Hematological Patients Treated with Anti-CD20 Monoclonal Antibodies: An International Multicenter Study
on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV), Jan 2025, In: Infectious Diseases and Therapy. 14, 1, p. 167-180 14 p., e068632.Research output: Contribution to journal › Article › peer-review
Open Access3 Link opens in a new tab Scopus citations -
Rapid whole genome characterization of antimicrobial-resistant pathogens using long-read sequencing to identify potential healthcare transmission
Wu, C. T., Shropshire, W. C., Bhatti, M. M., Cantu, S., Glover, I. K., Anand, S. S., Liu, X., Kalia, A., Treangen, T. J., Chemaly, R. F., Spallone, A. & Shelburne, S., Feb 1 2025, In: Infection Control and Hospital Epidemiology. 46, 2, p. 129-135 7 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Link opens in a new tab Scopus citations